Literature DB >> 21466622

CON: blood pressure treatment goal for patients with diabetes should be <130/80 mm Hg.

George L Bakris1.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21466622      PMCID: PMC8672985          DOI: 10.1111/j.1751-7176.2010.00415.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  13 in total

1.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Guy De Backer; Anna Dominiczak; Renata Cifkova; Robert Fagard; Giuseppe Germano; Guido Grassi; Anthony M Heagerty; Sverre E Kjeldsen; Stephane Laurent; Krzysztof Narkiewicz; Luis Ruilope; Andrzej Rynkiewicz; Roland E Schmieder; Harry A J Struijker Boudier; Alberto Zanchetti; Alec Vahanian; John Camm; Raffaele De Caterina; Veronica Dean; Kenneth Dickstein; Gerasimos Filippatos; Christian Funck-Brentano; Irene Hellemans; Steen Dalby Kristensen; Keith McGregor; Udo Sechtem; Sigmund Silber; Michal Tendera; Petr Widimsky; José Luis Zamorano; Serap Erdine; Wolfgang Kiowski; Enrico Agabiti-Rosei; Ettore Ambrosioni; Lars H Lindholm; Margus Viigimaa; Stamatis Adamopoulos; Enrico Agabiti-Rosei; Ettore Ambrosioni; Vicente Bertomeu; Denis Clement; Serap Erdine; Csaba Farsang; Dan Gaita; Gregory Lip; Jean-Michel Mallion; Athanasios J Manolis; Peter M Nilsson; Eoin O'Brien; Piotr Ponikowski; Josep Redon; Frank Ruschitzka; Juan Tamargo; Pieter van Zwieten; Bernard Waeber; Bryan Williams
Journal:  J Hypertens       Date:  2007-06       Impact factor: 4.844

2.  Intensive blood-pressure control in hypertensive chronic kidney disease.

Authors:  Lawrence J Appel; Jackson T Wright; Tom Greene; Lawrence Y Agodoa; Brad C Astor; George L Bakris; William H Cleveland; Jeanne Charleston; Gabriel Contreras; Marquetta L Faulkner; Francis B Gabbai; Jennifer J Gassman; Lee A Hebert; Kenneth A Jamerson; Joel D Kopple; John W Kusek; James P Lash; Janice P Lea; Julia B Lewis; Michael S Lipkowitz; Shaul G Massry; Edgar R Miller; Keith Norris; Robert A Phillips; Velvie A Pogue; Otelio S Randall; Stephen G Rostand; Miroslaw J Smogorzewski; Robert D Toto; Xuelei Wang
Journal:  N Engl J Med       Date:  2010-09-02       Impact factor: 91.245

3.  The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study.

Authors:  Mark J Sarnak; Tom Greene; Xuelei Wang; Gerald Beck; John W Kusek; Allan J Collins; Andrew S Levey
Journal:  Ann Intern Med       Date:  2005-03-01       Impact factor: 25.391

4.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

5.  Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.

Authors:  Rhonda M Cooper-DeHoff; Yan Gong; Eileen M Handberg; Anthony A Bavry; Scott J Denardo; George L Bakris; Carl J Pepine
Journal:  JAMA       Date:  2010-07-07       Impact factor: 56.272

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.

Authors:  J C Peterson; S Adler; J M Burkart; T Greene; L A Hebert; L G Hunsicker; A J King; S Klahr; S G Massry; J L Seifter
Journal:  Ann Intern Med       Date:  1995-11-15       Impact factor: 25.391

8.  Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study.

Authors:  Peter Sleight; Josep Redon; Paolo Verdecchia; Giuseppe Mancia; Peggy Gao; Robert Fagard; Helmut Schumacher; Michael Weber; Michael Böhm; Bryan Williams; Janice Pogue; Teo Koon; Salim Yusuf
Journal:  J Hypertens       Date:  2009-07       Impact factor: 4.844

9.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

10.  Lower blood pressure goals for cardiovascular and renal risk reduction: are they defensible?

Authors:  Rigas Kalaitzidis; George L Bakris
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-07       Impact factor: 3.738

View more
  3 in total

1.  Blood pressure targets in diabetes: is this the time for change?--PRO (Rebuttal).

Authors:  David M Kendall
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-04       Impact factor: 3.738

Review 2.  What is the ideal blood pressure goal for patients with diabetes mellitus and nephropathy?

Authors:  Mark L Lipman; Ernesto L Schiffrin
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

Review 3.  Evidence-based hypertension treatment in patients with diabetes.

Authors:  Mariana Garcia-Touza; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-12-19       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.